The short version
Just 3 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Avabenzone 3% Homosalate 10% Octisalate 5% · AVOBENZONE 3 g/100g; HOMOSALATE 10 g/100g; OCTISALATE 5 g/100g · Spray · Topical · Slam Lotion
NDC 85943-0002-05 · 142 g in 1 CAN · OTC MONOGRAPH DRUG · View full market →
Just 3 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.
How Part D pricing works →No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Not scored — fragility is computed for NADAC-priced NDCs.
No FDA shortage reports for this drug or its presentations.
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Dermatone Labs LLC | AVOBENZONE 3 g/100g; HOMOSALATE 10 g/100g; OCTISALATE 5 g/100g | Jul 15, 2026 | Sep 2, 2026 |
| The Soleil Group | AVOBENZONE 3 g/100g; HOMOSALATE 10 g/100g; OCTISALATE 5 g/100g | Jul 15, 2026 | Sep 2, 2026 |
| Slam Lotion | AVOBENZONE 3 g/100g; HOMOSALATE 10 g/100g; OCTISALATE 5 g/100g | Jul 15, 2026 | Aug 31, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Men scented sunscreen SPF 50 beachman SLAM — NDC 85943-0002-05," retrieved September 3, 2026, https://drugdashboards.com/drug/85943000205.
Free to cite with attribution — see how the data is put together.